Survival and histological evaluation of therapeutic window of post- ischemia treatment with magnesium sulfate in embolic stroke model of rat

Neuroscience Letters

Volumn 285, Issue 2, 2000, Pages 119-122

  Yang, Yi ^a   Li, Qiu ^a   Ahmad, Fayyaz ^a   Shuaib, Ashfaq ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Focal cerebral ischemia; Magnesium sulfate; Neuroprotection; Rats; Therapeutic window

Indexed keywords

MAGNESIUM SULFATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFICACY; HEART INFARCTION SIZE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL; TREATMENT OUTCOME;

ANIMALS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; DISEASE MODELS, ANIMAL; INFUSIONS, INTRAVENOUS; INTRACRANIAL EMBOLISM; MAGNESIUM SULFATE; MALE; RATS; RATS, WISTAR; SURVIVAL RATE; TIME FACTORS;

EID: 0034640147     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01048-X     Document Type: Article

References (15)

1. Ascher P., Nowak L. The role of divalent cations in the N-methyl-D-aspartate responses of mouse central neurons in culture. J. Physiol. (Lond.). 399:1988;247-266.
2. Freedman A.M., Mak I.T., Stafford R.E., Dickens B.F., Cassidy M.M., Muesing R.A., Weglicki W.B. Erythrocytes from magnesium-deficient hamsters display an enhanced susceptibility to oxidative stress. Am. J. Physiol. 62:1992;C1371-C1375.
3. Izumi Y., Roussel S., Pinard E., Seylaz J. Reduction of infarct volume by magnesium after middle cerebral artery occulusion in rats. J. Cereb. Blood Flow Metab. 11:1991;1025-1030.
4. Marinov M.B., Harbaugh K.S., Hoopes P.J., Pikus H.J., Harbaugh R.E. Neuroprotective effects of preischemia intraarterial magnesium sulfate in reversible focal cerebral ischemia. J. Neurosurg. 85:1996;117-124.
5. 2+ block site of the NMDA receptor channel. Nature. 358:1992;673-675.
6. Muir K.W. New experimental and clinical data on the efficacy of pharmacological magnesium infusions in cerebral infarcts. Magnesium Res. 11:1998;43-56.
7. Nishio A., Gebrewold A., Altura B.T., Altura B.M. Comparative vasodilator effects of magnesium salts on rat mesenteric arterioles and venules. Arch. Int. Pharmacodyn. Therap. 298:1989;139-163.
8. Rayssiguier Y., Durlach J., Gueux E., Rock E., Mazur A. Magnesium and aging. I. Experimental data: importance of oxidative damage. Magnesium Res. 6:1993;369-378.
9. Roffe C., Thomas L., Fotheringham A., Davies A. The effect of magnesium on infarct size and oedema after middle cerebral artery occlusion. Cerebrovasc. Dis. 6:(Suppl. 2):1996;42.
10. Schmid-Elsaesser R., Zausinger S., Hungerhuber E., Baethmann A., Reulen H.J. Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia. Neurosurgery. 44:1999;163-171.
11. Shuaib A., Yang Y., Li Q., Siddiqui M.M., Kalra J. Intraarterial urokinase produces significant attenuation of infarction volume in an embolic focal ischemia model. Exp. Neuro. 154:1998;330-335.
12. 2+ administrated up to 24 h following reperfusion prevented ischemic damage of the CA1 neurons in the rat hippocamus. Neuroscience. 44:1991;335-341.
13. Weglicki W.B., Phillips T.M. Pathobiology of magnesium deficiency: a cytokine/neurogenic inflammation hypothesis. Am. J. Physiol. 263:1992;R734-R737.
14. Yang Y., Shuaib A., Li Q. Quantification of infarct size on focal cerebral ischemia modal of rats using a simple and economical method. J. Neurosci. Methods. 84:1998;9-16.
15. Zhang Z., Zhang R.L., Jiang Q., Raman S.B.K., Cantwell L., Chopp M. A new rat model of thrombotic focal cerebral ischemia. J. Cereb. Blood Flow Metab. 17:1997;123-135.